全文获取类型
收费全文 | 11838篇 |
免费 | 548篇 |
国内免费 | 82篇 |
专业分类
耳鼻咽喉 | 269篇 |
儿科学 | 494篇 |
妇产科学 | 394篇 |
基础医学 | 1072篇 |
口腔科学 | 433篇 |
临床医学 | 986篇 |
内科学 | 2770篇 |
皮肤病学 | 189篇 |
神经病学 | 722篇 |
特种医学 | 519篇 |
外科学 | 2367篇 |
综合类 | 267篇 |
一般理论 | 4篇 |
预防医学 | 477篇 |
眼科学 | 282篇 |
药学 | 665篇 |
中国医学 | 41篇 |
肿瘤学 | 517篇 |
出版年
2024年 | 9篇 |
2023年 | 116篇 |
2022年 | 254篇 |
2021年 | 429篇 |
2020年 | 222篇 |
2019年 | 311篇 |
2018年 | 357篇 |
2017年 | 259篇 |
2016年 | 400篇 |
2015年 | 441篇 |
2014年 | 548篇 |
2013年 | 632篇 |
2012年 | 809篇 |
2011年 | 823篇 |
2010年 | 488篇 |
2009年 | 420篇 |
2008年 | 800篇 |
2007年 | 907篇 |
2006年 | 888篇 |
2005年 | 810篇 |
2004年 | 698篇 |
2003年 | 564篇 |
2002年 | 496篇 |
2001年 | 90篇 |
2000年 | 82篇 |
1999年 | 69篇 |
1998年 | 63篇 |
1997年 | 43篇 |
1996年 | 54篇 |
1995年 | 31篇 |
1994年 | 21篇 |
1993年 | 22篇 |
1992年 | 25篇 |
1991年 | 22篇 |
1990年 | 24篇 |
1989年 | 31篇 |
1988年 | 22篇 |
1987年 | 19篇 |
1986年 | 22篇 |
1985年 | 18篇 |
1984年 | 9篇 |
1983年 | 12篇 |
1982年 | 8篇 |
1980年 | 7篇 |
1979年 | 8篇 |
1978年 | 11篇 |
1974年 | 9篇 |
1973年 | 9篇 |
1972年 | 8篇 |
1971年 | 8篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
Karaosmanoglu Ali Devrim Onur Mehmet Ruhi Salman Mehmet Coskun Usubutun Alp Karcaaltincaba Musturay Ozmen Mustafa Nasuh Akata Deniz 《Abdominal imaging》2019,44(4):1493-1505
Abdominal Radiology - Metastatic involvement of the ovaries is not rare. The most common tumor types metastasizing to the ovaries, from non-gynecological organs, are breast, colorectal, gastric,... 相似文献
2.
3.
4.
5.
6.
Rebecca Wright Caleb Ferguson Mustafa Bodrick Hanan Balkhy Debra Jackson Patricia M. Davidson 《Journal of clinical nursing》2020,29(13-14):2723-2729
7.
Alper Kurtoglu Alauddin Kochai Mustafa Erkan Inanmaz Erhan Sukur Dogan Keskin Mehmet Türker Mustafa Uysal Zafer Sen Ismail Daldal 《Medicine》2021,100(13)
Different methods have been used throughout the years for syndesmotic injury but there is no consensus on the ideal treatment. Some methods are expensive and some have more complications. The aim of this study is to compare single suture endobutton with double suture endobutton and screw fixation for syndesmotic injury.Sixty nine patients with syndesmotic injury with fibular fractures whom were treated with a single interosseous suture endobutton system (ZipTightTM, Zimmer Biomet), a double interosseous suture endobutton system (ZipTightTM, Zimmer Biomet) and 1 syndesmotic screw (TST, Istanbul, Turkey) were included in this study. Functional and radiological results from patient records between 2015 and 2018 were retrospectively evaluated.Twenty patients were treated with the double interosseous suture endobutton, 23 were treated with the single interosseous suture endobutton, and 26 were treated with traditional AO screw fixation. Three patients from the screw fixation group (11.5%) required revision surgery (P < .05). All the radiologic and clinical outcomes were statistical similar in all 3 groups.Our findings showed that the interosseous suture endobutton system is at least as safe as the screw fixation technique for treatment of syndesmosis joint injuries and can be used as an alternative to the screw method. The interosseous suture endobutton system eliminates the need for a second surgery to remove the hardware, which minimizes the probability of re-diastasis. Since our results showed no statistical difference between single and double interosseous suture endobutton systems, the less costly single endobutton system may be the better alternative. 相似文献
8.
9.
10.
Expression of TRIM22 mRNA in chronic hepatitis C patients treated with direct-acting antiviral drugs
Mariam Naveed Amjad Ali Nadeem Sheikh Shazia Rafique Muhammad Idrees 《APMIS : acta pathologica, microbiologica, et immunologica Scandinavica》2020,128(4):326-334
Hepatitis C is a global public health problem, and Pakistan is the second largest country in the globe with highest prevalence rate of hepatitis C virus (HCV). Until 2014, pegylated interferon (PEG-IFN) plus ribavirin (RBV) has been the standard therapy for HCV, however, owing to its adverse side effects and very low sustained virologic response (SVR) rates therapeutics trend is shifted toward direct-acting antivirals. Tripartite motif containing 22 (TRIM22) is a dynamic antiviral protein that can inhibit multiple viruses in vivo. Expression of TRIM22 mRNA has been linked to outcome of PEG-IFN and ribavirin therapy, where its higher expression leads to rapid virus clearance. However, in terms of therapy with direct-acting antiviral (DAA) or double DAA, impact of TRIM22 expression is largely unknown. These new drugs show more than 90% of SVR rates and lesser side effects and have proven to be better than IFN therapy. Endogenous IFN system suppresses various pathogens through the induction of antiviral effectors termed as interferon-stimulating genes (ISGs). We have studied the expression levels of one of these antiviral effectors, TRIM22 in response to sofosbuvir (SOF) and daclatasvir (DAC) in combination with RBV, using quantitative PCR in the peripheral blood mononuclear cells (PBMCs) of HCV-infected patients. We have observed sustained virus clearance in more than 90% of patients treated with DAA and double DAA and have seen the expression of TRIM22 to be higher in patients who attained SVR as compared to the untreated patients. We have also observed downregulation of TRIM22 in patients who failed to attain rapid virus clearance, and upregulation in those who achieved rapid clearance of virus. Genetic factors that determine the lower TRIM22 expression in these patients are needed to be explored that may also play a role in lower response to anti-HCV therapy. Endogenous IFN system and effects of antiviral proteins in response to DAA therapy is needed to be studied in order to better understand the host response toward these drugs to make them more effective. 相似文献